Mary J Roman

Author PubWeight™ 175.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 46.32
2 Recommendations for chamber quantification. Eur J Echocardiogr 2006 11.39
3 Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med 2014 5.11
4 Aneurysms of the sinuses of Valsalva. Cardiology 2006 3.64
5 Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008 3.16
6 Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007 2.94
7 Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 2009 2.58
8 Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008 2.52
9 Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 2009 2.33
10 Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol 2003 2.20
11 Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 2007 2.14
12 Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006 2.08
13 Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002 2.05
14 Assessment of the thoracic aorta by multidetector computed tomography: age- and sex-specific reference values in adults without evident cardiovascular disease. J Cardiovasc Comput Tomogr 2008 2.04
15 Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 2006 2.00
16 Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke 2005 1.96
17 Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol 2008 1.91
18 Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol 2008 1.81
19 Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens 2005 1.79
20 Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation 2007 1.78
21 Ethnic differences in arterial wave reflections and normative equations for augmentation index. Hypertension 2011 1.77
22 Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008 1.70
23 Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study. J Hypertens 2003 1.69
24 Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: the Genetics of Coronary Artery Disease in Alaska Natives study. Atherosclerosis 2007 1.68
25 Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation 2007 1.67
26 Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J Hypertens 2011 1.61
27 Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study. J Am Coll Cardiol 2002 1.56
28 Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension 2005 1.53
29 Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 2004 1.49
30 Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging 2009 1.48
31 Lack of associations of ten candidate coronary heart disease risk genetic variants and subclinical atherosclerosis in four US populations: the Population Architecture using Genomics and Epidemiology (PAGE) study. Atherosclerosis 2013 1.48
32 Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004 1.48
33 A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health 2005 1.43
34 Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation 2008 1.36
35 Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension 2005 1.35
36 Heritability of left ventricular dimensions and mass in American Indians: The Strong Heart Study. J Hypertens 2004 1.30
37 Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age. Am J Cardiol 2012 1.29
38 Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension 2009 1.26
39 Cardiac chamber volumes, function, and mass as determined by 64-multidetector row computed tomography: mean values among healthy adults free of hypertension and obesity. JACC Cardiovasc Imaging 2008 1.26
40 Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006 1.23
41 Heritability of carotid artery structure and function: the Strong Heart Family Study. Arterioscler Thromb Vasc Biol 2002 1.20
42 Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 2003 1.20
43 Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J 2003 1.09
44 Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS). Am Heart J 2006 1.08
45 Systemic lupus erythematosus predicts increased left ventricular mass. Circulation 2007 1.07
46 Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 2003 1.07
47 Left atrial systolic force and cardiovascular outcome. The Strong Heart Study. Am J Hypertens 2005 1.03
48 PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. J Clin Lipidol 2009 1.02
49 Genetic influences on aortic root size in American Indians: the Strong Heart Study . Arterioscler Thromb Vasc Biol 2002 1.01
50 Mechanisms of verbal memory impairment in four neurodevelopmental disorders. Brain Lang 2004 0.99
51 Depressive symptoms are independently predictive of carotid atherosclerosis. Am J Cardiol 2005 0.99
52 Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Am J Cardiol 2006 0.98
53 Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart Study. Am Heart J 2003 0.98
54 Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes 2002 0.98
55 Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study. J Hypertens 2008 0.97
56 The right sided great vessels by cardiac multidetector computed tomography: normative reference values among healthy adults free of cardiopulmonary disease, hypertension, and obesity. Acad Radiol 2009 0.97
57 Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study. Hypertension 2007 0.95
58 34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J Am Coll Cardiol 2003 0.94
59 An appraisal of echocardiography as an epidemiological tool. The Strong Heart Study. Ann Epidemiol 2003 0.93
60 Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Am J Cardiol 2002 0.92
61 Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study. Diabetes Care 2011 0.92
62 Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study. Am Heart J 2003 0.91
63 Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study. Am J Hypertens 2006 0.90
64 Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study. Stroke 2008 0.90
65 Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study). Am J Cardiol 2004 0.90
66 Atherosclerosis in survivors of Kawasaki disease. J Pediatr 2009 0.89
67 Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study. J Am Soc Echocardiogr 2007 0.88
68 Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study. Diabetes Care 2012 0.88
69 Genome-wide linkage analysis of pulse pressure in American Indians: the Strong Heart Study. Am J Hypertens 2008 0.87
70 A quantitative trait loci-specific gene-by-sex interaction on systolic blood pressure among American Indians: the Strong Heart Family Study. Hypertension 2006 0.87
71 Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: the Strong Heart Family Study. Aging (Albany NY) 2014 0.87
72 Prevalence of smoking and its relationship with carotid atherosclerosis in Alaskan Eskimos of the Norton Sound region: the GOCADAN study. Nicotine Tob Res 2008 0.86
73 Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. Int J Cardiol 2012 0.85
74 Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study. Hypertension 2004 0.85
75 C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study. J Am Coll Cardiol 2005 0.85
76 GenTAC registry report: gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissection. Am J Med Genet A 2013 0.85
77 Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. Stroke 2011 0.83
78 The ratio of mitral deceleration time to E-wave velocity and mitral deceleration slope outperform deceleration time alone in predicting cardiovascular outcomes: the Strong Heart Study. J Am Soc Echocardiogr 2007 0.82
79 Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study). Am J Cardiol 2009 0.82
80 Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc 2013 0.82
81 Usefulness of quantitative assessment of electrocardiographic ST depression for predicting new-onset heart failure in American Indians (from the Strong Heart Study). Am J Cardiol 2007 0.81
82 Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography. Am J Cardiol 2007 0.81
83 Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study). Am J Cardiol 2009 0.81
84 Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study. Echocardiography 2007 0.81
85 Genome-wide linkage analysis of carotid artery lumen diameter: the strong heart family study. Int J Cardiol 2013 0.81
86 Valve-sparing aortic root replacement in patients with Marfan syndrome enrolled in the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions. J Heart Valve Dis 2014 0.80
87 Ruptured aneurysm of the right sinus of valsalva associated with a ventricular septal defect and an anomalous coronary artery. Tex Heart Inst J 2005 0.80
88 Central blood pressure measurements-an opportunity for efficacy and safety in drug development? J Am Soc Hypertens 2010 0.79
89 Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2013 0.78
90 Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis Rheum 2010 0.77
91 Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study. Am J Med 2002 0.77
92 Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest. Am J Cardiol 2005 0.76
93 Letter by O'Rourke et al regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study". Circulation 2010 0.76
94 Myocardial function and geometry in hypertensive subjects with low levels of afterload. Am Heart J 2002 0.75
95 Questions regarding the aortic measurements of Mitchell et al. Hypertension 2008 0.75
96 Left ventricular systolic dysfunction in rheumatoid disease. J Am Coll Cardiol 2006 0.75
97 Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus. Arthritis Rheum 2012 0.75
98 Niacin compared with ezetimibe. N Engl J Med 2010 0.75
99 Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens 2012 0.75
100 Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population. J Clin Hypertens (Greenwich) 2007 0.75
101 Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus. Nat Clin Pract Rheumatol 2007 0.75
102 Red meat consumption and cardiovascular target organ damage (from the Strong Heart Study). J Hypertens 2017 0.75
103 Blood pressure normalization is associated with normal left ventricular mass but not carotid geometry: the ICARe Dicomano Study. J Hypertens 2006 0.75
104 Prevalence and correlates of rheumatic heart disease in American Indians (the Strong Heart Study). Am J Cardiol 2003 0.75